Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism.
Satoko Kawarasaki; Honami Sawazaki; Hiroaki Iijima; Su-Ping Ng; Jungin Kwon; Shinsuke Mohri; Mari Iwase; Huei-Fen Jheng; Haruya Takahashi; Wataru Nomura; Kazuo Inoue; Teruo Kawada; Tsuyoshi Goto
Diabetes, metabolic syndrome and obesity : targets and therapy, 2020年11月, 査読有り